Time of day immunotherapy rx: “early-infusion group had a median progression-free survival (PFS) of 11.3 months, while the late-infusion group’s median PFS was 5.7 months”

Posted on by

https://www.science.org/content/blog-post/get-early-start

Astonishing! Thought to be circadian T cell variation but absolutely nobody expected an effect this size. Lots of studies coming on this.